IPAD-DB ID | D00929 |
Name | 4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 6 H 2 0 N 2 |
Molecular Weight | 240.34 |
IUPAC Name | 4-methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine |
InChI | InChI=1S/C16H20N2/c1-13-9-10-16(15(17)12-13)18-11-5-8-14-6-3-2-4-7-14/h2-4,6-7,9-10,12,18H,5,8,11,17H2,1H3 |
InChIKey | YMFNPBSZFWXMAD-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC(=C(C=C1)NCCCC2=CC=CC=C2)N |
PubChem CID | 16760588 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 240.34 |
Hac(Computed by SwissADME) | 18 |
Volume(Computed by ADMETlab 2.0) | 274.354 |
Density(Computed by ADMETlab 2.0) | 0.875 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 2 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 12 |
Flexibility(Computed by ADMETlab 2.0) | 0.417 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.279 |
LogD(Computed by ADMETlab 2.0) | 3.52 |
logP(Computed by ADMETlab 2.0) | 3.516 |
TPSA(Computed by SwissADME) | 38.05 |
Hbond Acceptor(Computed by SwissADME) | 0 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 5 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -5 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |